Gefitinib approved for first-line EGFR-positive metastatic NSCLC http://bit.ly/1KkFZ0k
11:02 AM - 22 Jul 2015
0 replies
1 retweet
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.